SAREPTA THERAPEUTICS, INC.

Lobbying for SAREPTA THERAPEUTICS, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $220,000.00 expenses · posted Jul 20, 2026

Bills named in this filing 2

HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
HR 1509
Accelerating Kids’ Access to Care Act of 2025

Lobbying activity 4

Budget/Appropriations

H.R. 9260 - LHHS Appropriations

Health Issues

H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment

Science/Technology

National Security Commission on emerging biotechnology policy proposals

Trade (domestic/foreign)

Issues related to supply chain Issues related to Section 232

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.